September 20th, 2012
Why I Applaud the Skeptical Physicians
Joseph S. Ross, MD, MHS
Is skepticism of industry-funded trials warranted even when they are designed, conducted, and reported with the utmost rigor?
September 3rd, 2010
ESC: Similarities and Differences
Susan Cheng, MD
Many things about ESC felt different compared to other conferences I’ve attended — and as many felt the same. The basics were familiar— the welcome booths, the exhibits, and the masses of semi-serious looking people sporting the requisite badge-plus-bag accessory combo. (Thank goodness the bags were bright green and easy to spot from a mile away, […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?